NASDAQ · ASTH
Healthcare · Medical - Care Facilities
$34.36
Up+$0.06 (+0.17%)
Updated Sep 20, 2026, 8:01 AM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
ASTH closed at $34.36 after 19 trading sessions, down 9.84% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $33.87 | $35.215 | $33.1401 | $34.36 | 1.44M |
| Sep 17, 2026 | $37.96 | $38.1605 | $34.17 | $34.30 | 1.05M |
| Sep 16, 2026 | $38.35 | $39.52 | $37.60 | $37.70 | 263.46K |
| Sep 15, 2026 | $39.70 | $39.70 | $38.00 | $38.35 | 314.33K |
| Sep 14, 2026 | $38.21 | $39.95 | $38.21 | $39.60 | 321.27K |
| Sep 11, 2026 | $38.45 | $38.88 | $37.585 | $37.98 | 191.72K |
| Sep 10, 2026 | $38.06 | $39.40 | $37.48 | $38.03 | 264.19K |
| Sep 9, 2026 | $37.87 | $38.20 | $36.66 | $38.06 | 197.07K |
| Sep 8, 2026 | $38.195 | $38.28 | $37.24 | $38.10 | 304.98K |
| Sep 4, 2026 | $37.65 | $39.24 | $37.2182 | $38.47 | 241.95K |
| Sep 3, 2026 | $38.80 | $38.945 | $37.53 | $37.83 | 380.28K |
| Sep 2, 2026 | $38.71 | $39.235 | $38.44 | $38.57 | 305.49K |
| Sep 1, 2026 | $38.04 | $39.39 | $37.69 | $38.60 | 301.33K |
| Aug 31, 2026 | $37.63 | $38.61 | $37.505 | $38.11 | 235.23K |
| Aug 28, 2026 | $38.46 | $38.68 | $37.66 | $37.96 | 368.7K |
| Aug 27, 2026 | $38.27 | $38.59 | $37.5311 | $38.41 | 281.24K |
| Aug 26, 2026 | $37.64 | $39.36 | $37.07 | $38.61 | 281.14K |
| Aug 25, 2026 | $38.11 | $38.11 | $36.6001 | $37.61 | 362.72K |
| Aug 24, 2026 | $39.18 | $39.8545 | $37.90 | $38.11 | 371.37K |
The latest Smart Investors Daily articles mentioning ASTH.
ASTH research
Company profile and research snapshot.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 15, 2026 | Oppenheimer | Outperform | — |
| Aug 11, 2026 | Truist Securities | Buy | — |
| Aug 7, 2026 | Barclays | Overweight | — |
| Jul 14, 2026 | TD Cowen | Buy | — |
| Jul 14, 2026 | BTIG | Buy | — |
No generated briefing is available yet.
Benzinga · Sep 15, 2026
Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.
SeekingAlpha · Aug 12, 2026
Astrana Health (ASTH) buy thesis: 46% peer discount, Care Enablement margins, capitation-led growth, and $48 PT (+28%).
Benzinga · Aug 11, 2026
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $47 to $55.
Benzinga · Aug 7, 2026
Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Overweight and raises the price target from $50 to $53.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ASTH.
